EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparing Functional Consequences of Human iPSC ‐Microglia and Neural Stem Cell‐Derived Extracellular Vesicles in Mitigating Cognitive Decline in Alzheimer's Disease

Robert P Krattli, Mineh Markarian, Shreya Madan, Devyani Swami, Amanda McQuade, Janet E Baulch, Matthew Blurton-Jones, Munjal M Acharya iD

Aging Cell · 2026-01 · 25 (1)

DOI: 10.1111/acel.70341 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Aging Cell, online erschienen am 23.12.2025. Verfasst von Robert P Krattli und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy & Neurobiology, University of California Irvine, Irvine, California, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Extracellular Vesicles, Microglia, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. National Institutes of Health (NIH), California Institute for Regenerative Medicine, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stem cell‐derived extracellular vesicles (EVs) show promise as a therapeutic approach for neurodegenerative diseases, particularly Alzheimer's Disease (AD), where traditional regenerative interventions have achieved limited success. Our previous research demonstrated the neuroprotective benefits of human neural stem cell (hNSC)‐derived EVs in 2‐ and 6‐month‐old AD mice (5xFAD) that exibited improved cognitive function and reduced AD‐related neuropathology. This study aimed to compare the neuroprotective efficacy of EVs derived from two human cell lines: hNSCs from H9 embryonic stem cells and human iPSC‐derived microglia (iMGLs). Additionally, we investigated the efficacy of an expanded EV treatment paradigm at subsequently longer time points. Three‐month‐old 5xFAD mice received weekly retro‐orbital vein injections of either hNSC‐ or iMGL‐derived EVs for 4 weeks. Cognitive function testing revealed comparable cognitive improvements in both EV treatment groups compared to vehicle‐injected AD mice. Both iMGL‐ and hNSC‐derived EVs significantly reduced amyloid beta plaques, astrogliosis, and microglial activation, while restoring synaptophysin and postsynaptic density protein PSD‐95 to control levels in AD brains. Gene expression analysis revealed significantly reduced neuroinflammation and elevated neuroprotective signatures following both EV treatments. MicroRNA analysis of the EV‐derived cargo revealed unique and shared miRNA signatures associated with differentially expressed genes in both cell lines. These findings demonstrate the feasibility and neuroprotective benefits of recurrent systemic injections of EVs derived from human NSCs and differentiated human microglia lines in alleviating cognitive dysfunction and neuropathology in Alzheimer's disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseExtracellular VesiclesMicrogliaInduced Pluripotent Stem CellsNeural Stem CellsCognitive DysfunctionHumansAnimalsMiceDisease Models, Animal

Stichwörter der Autor:innen

Alzheimer's diseaseamyloid beta plaquescognitive functionextracellular vesicleshuman induced pluripotent stem cells (iPSC)human microgliahuman neural stem cellsmicroglial activationneuroinflammation

Autor:innen und Institutionen

  • Department of Anatomy & Neurobiology, University of California Irvine, Irvine, California, USA.
  • Department of Neurobiology & Behavior, University of California Irvine, Irvine, California, USA.
  • Department of Radiation Oncology, University of California Irvine, Irvine, California, USA.

ORCID-Profile: Munjal M Acharya

Förderung

  • U.S. National Institutes of Health (NIH)
  • California Institute for Regenerative Medicine
  • NCI NIH HHS
  • UC Irvine Sue and Bill Gross Stem Cell Research Center

Zitieren

APA

Krattli, R. P., Markarian, M., Madan, S., Swami, D., McQuade, A., Baulch, J. E., Blurton-Jones, M., & Acharya, M. M. (2026). Comparing Functional Consequences of Human iPSC ‐Microglia and Neural Stem Cell‐Derived Extracellular Vesicles in Mitigating Cognitive Decline in Alzheimer's Disease. Aging Cell, 25(1). https://doi.org/10.1111/acel.70341

Vancouver

Krattli RP, Markarian M, Madan S, Swami D, McQuade A, Baulch JE, et al. Comparing Functional Consequences of Human iPSC ‐Microglia and Neural Stem Cell‐Derived Extracellular Vesicles in Mitigating Cognitive Decline in Alzheimer's Disease. Aging Cell. 2026;25(1). doi:10.1111/acel.70341

BibTeX
@article{Krattli2026,
  author = {Krattli, Robert P and Markarian, Mineh and Madan, Shreya and Swami, Devyani and McQuade, Amanda and Baulch, Janet E and Blurton-Jones, Matthew and Acharya, Munjal M},
  title = {Comparing Functional Consequences of Human iPSC ‐Microglia and Neural Stem Cell‐Derived Extracellular Vesicles in Mitigating Cognitive Decline in Alzheimer's Disease},
  journal = {Aging Cell},
  year = {2026},
  volume = {25},
  number = {1},
  doi = {10.1111/acel.70341}
}
Kostenlos starten →